Discontinuation report OLANZAPINE FOR INJECTION

Last updated on 2020-06-22 History
Report ID 118553
Drug Identification Number 02416522
Brand name OLANZAPINE FOR INJECTION
Common or Proper name OLANZAPINE FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) OLANZAPINE
Strength(s) 10MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size I PSIJ
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2020-06-19
Remaining supply date 2020-06-19
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-06-22 French Compare
v1 2020-06-22 English Compare

Showing 1 to 2 of 2